The psychedelic drugs industry is witnessing dynamic growth fueled by increasing acceptance for therapeutic applications and expanding research on mental health treatments. Innovations in formulation and clinical trials primarily targeting depression, PTSD, and anxiety disorders are reshaping the market landscape. These developments are reflected in the recent market size and forecast...